SFDA issues interim measures for drug supervision and management in medical institutions *

China - February 6 2012
After two rounds of seeking comments in 2010, the SFDA in October 2011 issued measures officially regulating drugs in medical institutions for the first time.

Co-authors: Isabella Liu, Michelle Y.L. Gon, Clement Ngai.

Further guidance on investing in China with offshore RMB funds *

China - October 31 2011
On 12 October 2011, the PRC Ministry of Commerce announced further detailed rules for foreign investors to use their offshore RMB funds to invest in China under the 16-articled Notice of the Ministry of Commerce on Issues relating to Cross-border RMB Direct Investment (Shang Zi Han [2011] No. 889).

Co-authors: Clara Ingen-Housz, Andreas W. Lauffs, Nancy Leigh.

Update on China’s national security review regime: list of sensitive industries revealed *

China - October 31 2011
In recent weeks, especially since the Ministry of Commerce (“MOFCOM”) issued Circular 53 (on implementation of the foreign investment national security review regime for acquisitions; see our earlier Client Alert*) on 25 August 2011, various local commerce bureaus have posted on their websites a Security Review Industry Table listing 57 non-defense industries within the types of industries set out generically in the definition of the scope of the national security review under Circular 6.

Co-authors: Clara Ingen-Housz, Andreas W. Lauffs, Nancy Leigh.